Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTirzepatide medication interactions are less numerous than with many common drugs, but a handful are clinically significant — particularly around oral contraceptives, blood-glucose medicines, and anything that alters gastric emptying. Mounjaro is a prescription-only medicine that slows how quickly your stomach empties, and that single mechanism sits at the heart of most interaction questions worth raising with your prescriber. The sections below walk through the real-world checking sequence a clinician follows, so you arrive at your consultation with the right information ready.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The single most useful thing you can do in the next sixty seconds is open the NHS App (or pull out your repeat prescription bag) and count every medicine, supplement and herbal product you take regularly. That list is what a prescriber needs, and it is what makes an interaction review meaningful rather than theoretical.
Tirzepatide, the active ingredient in Mounjaro, works partly by slowing gastric emptying. That delay can push back the peak blood concentration of any oral medicine taken at the same time. For most drugs the shift is small enough not to matter clinically. For a few it is not. The GLP-1 and dual-agonist class as a whole has been studied carefully for this, and the evidence is reassuring for the majority of commonly prescribed drugs, but the exceptions deserve careful attention.
When you bring your list to consultation, include over-the-counter medicines and anything bought online. Ibuprofen, for instance, or herbal supplements with blood-pressure effects, can complicate the picture in ways that are easy to miss if they are not declared. A prescriber cannot assess what they cannot see. More detail on how a full medication review fits into the prescribing process is on the Mounjaro prescribing overview page.
Once your list is ready, a prescriber is broadly looking for three things.
Blood-glucose medicines. If you take insulin, a sulfonylurea (such as gliclazide or glibenclamide), or any other diabetes medication that can cause hypoglycaemia on its own, combining it with tirzepatide raises the risk further. Mounjaro lowers blood glucose independently; the doses of other agents usually need reviewing before or shortly after starting. This is one of the most common practical adjustments. The BNF entry for tirzepatide lists recognised interactions with antidiabetic drugs and flags the monitoring requirements clearly.
Oral contraceptives. NHS guidance advises women on the combined or progestogen-only pill to use an additional non-oral contraceptive method (condoms, for example) during the first four weeks of Mounjaro treatment and for four weeks after each dose step upward. There is no equivalent evidence of this effect with semaglutide. Switching to a patch, ring or implant removes the concern altogether; a prescriber or GP can advise on the best option for you personally. If you want more detail, the interaction pages for specific drug classes cover this territory.
Narrow-therapeutic-index medicines. Drugs where a small shift in blood levels has a large clinical effect (certain anticoagulants, anticonvulsants, or thyroid medicines) need particular attention. Gastric slowing can delay absorption enough to change the timing of the drug's peak effect. The prescriber may time your dose differently or ask your GP to monitor levels more closely while you adjust.
Clinical pharmacokinetic studies conducted as part of the tirzepatide development programme looked at a range of co-administered drugs, including atorvastatin, digoxin, metformin, warfarin, ethinylestradiol and levonorgestrel. For most, the effect of tirzepatide on absorption was modest and within the range considered clinically acceptable. Warfarin is worth singling out: international normalised ratio (INR) monitoring is recommended when starting tirzepatide, not because the interaction is dramatic, but because even a small drift matters with anticoagulants.
The NHS medicines page for tirzepatide lists the interactions that patients should know about in plain language, and the full prescribing information on the electronic Medicines Compendium (eMC) covers the pharmacokinetic data in detail for clinicians. Both are worth checking alongside your own medication list, and our guide to whether Mounjaro interacts with medications walks through the most clinically relevant combinations in straightforward terms.
What the studies do not capture is every possible combination in every patient. Polypharmacy (taking five or more medicines simultaneously) is common in people with obesity and related conditions, and the interactions among multiple drugs are harder to predict from first principles. That is why a comprehensive medicine review, not just a quick checklist, is the standard at a clinician-led service. If you are comparing private providers, the cost and service comparison page explains what a thorough clinical review involves and why the absence of one is a genuine safety concern.
Interactions are not a one-time check. If your GP starts a new medicine after you have been on Mounjaro for several months, or if you switch from one formulation to another, the interaction picture can change. Equally, as your dose increases (from 2.5mg through the titration schedule) the gastric-emptying effect may strengthen slightly, which can shift absorption profiles for sensitive drugs.
At every repeat prescription review, a clinician should be asking whether anything in your medication list has changed. At nume's pharmacy, that question is built into every repeat order, a GPhC-registered prescriber reads your updated health information before any medicine is dispensed, not as a formality but as the actual check it is supposed to be. If something has changed and you are unsure whether it matters, the fastest route is to contact the prescribing team directly rather than waiting for your next scheduled review. The FAQs page addresses some of the most common mid-treatment queries, or you can reach the team through the contact page any day of the week.
Starting a structured review of your medicines is the practical step that sits before any prescribing decision. If you would like a prescriber to assess your full medication list as part of a weight-management consultation, start your free consultation and our team will review everything the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.